Second cancers in patients with brain tumours-impact of treatment

By Salminen E.   Pukkala E.   Teppo L.  

European Journal of Cancer, Vol. 35, Iss. 1, 1999-01 ,pp. : 102-105

Elsevier

Access to resources Recommend Favorite

Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours

By Poulsen Hans Skovgaard   Grunnet Kirsten   Sorensen Morten   Olsen Preben   Hasselbalch Benedikte   Nelausen Knud   Kosteljanetz Michael   Lassen Ulrik  

Acta Oncologica, Vol. 48, Iss. 1, 2009-01 ,pp. : 52-58

Informa Healthcare

Access to resources Recommend Favorite

Tamoxifen Paradoxically Decreases Paclitaxel Deposition into Cerebrospinal Fluid of Brain Tumor Patients

By Chen Johnson   Balmaceda Casilda   Bruce Jeffrey   Sisti Michael   Huang May   Cheung Ying   McKhann Guy   Goodman Robert   Fine Robert  

Journal of Neuro-Oncology, Vol. 76, Iss. 1, 2006-01 ,pp. : 85-92

Springer Publishing Company

Access to resources Recommend Favorite

The frequency and cause of anxiety and depression amongst patients with malignant brain tumours between surgery and radiotherapy

By Kilbride Lynn   Smith Graeme   Grant Robin  

Journal of Neuro-Oncology, Vol. 84, Iss. 3, 2007-09 ,pp. : 297-304

Springer Publishing Company

Access to resources Recommend Favorite

The Early Effects of Radiotherapy on Intellectual and Cognitive Functioning in Patients with Frontal Brain Tumours: The Use of a New Neuropsychological Methodology

By Costello Angela   Shallice Tim   Gullan Richard   Beaney Ron  

Journal of Neuro-Oncology, Vol. 67, Iss. 3, 2004-05 ,pp. : 351-359

Springer Publishing Company

Access to resources Recommend Favorite